Task: Answer the multiple-choice question.
Query: Which drug exhibits a 3.847% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCOCCc1nnc(NC(=O)CS(=O)(=O)c2ccc(C)cc2)s1
b Cc1ccccc1C(=O)NC1CCN(Cc2nnnn2C2CCCC2)CC1
c O=C(c1sccc1Br)N1CCN(Cc2ccc3c(c2)OCO3)CC1
Answer: b. Cc1ccccc1C(=O)NC1CCN(Cc2nnnn2C2CCCC2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1C(=O)NC1CCN(Cc2nnnn2C2CCCC2)CC1
Cc1ccccc1C(=O)NC1CCN(Cc2nnnn2C2CCCC2)CC1
N-[1-[(1-cyclopentyltetrazol-5-yl)methyl]piperidin-4-yl]-2-methylbenzamide